Aug 2026· Cellular Signalling· Vol 148, pp.
112839
· 0 citations· 39 references
Medicine
TL;DR
PFKL plays a key role in coordinating LD-mitochondria tethering under glucose deprivation in PDAC, and targeting the p38-PFKL-PLIN2-CPT1A axis may represent a promising therapeutic strategy.
Abstract
BACKGROUND/
Objective
Lipid droplet (LD)-mitochondria tethering is essential for fatty acid oxidation (FAO), which sustains tumor cell survival under nutrient-deprivation conditions. However, how LD-mitochondria contact is regulated in pancreatic ductal adenocarcinoma (PDAC) is unclear.
Methods
This study investigated the signaling pathway that regulates lipid droplet-mitochondria interaction in PDAC under conditions of glucose deprivation, utilizing molecular interaction assays, cellular functional experiments, and clinical sample validation.
Results
Glucose deprivation activated p38, leading to phosphorylation of phosphofructokinase, liver type (PFKL) at T331, which in turn phosphorylated the LD protein perilipin 2 (PLIN2) at S159 in PDAC cells. This enhanced the binding of PLIN2 to mitochondrial protein carnitine palmitoyltransferase-1 A (CPT1A), thereby promoting LD-mitochondria tethering. Disruption of this axis impaired LD-mitochondria contact, reduced lipid consumption and ATP production, decreased cell viability, increased apoptosis, and suppressed tumor growth. In human PDAC samples, phosphorylation levels at both PFKL T331 and PLIN2 S159 were elevated and showed a positive correlation.
Conclusion
PFKL plays a key role in coordinating LD-mitochondria tethering under glucose deprivation in PDAC, and targeting the p38-PFKL-PLIN2-CPT1A axis may represent a promising therapeutic strategy.
Background/Objectives: Metabolic reprogramming is a hallmark of cancer and requires coordinated regulation of glycolysis and mitochondrial metabolism. The pyruvate dehydrogenase complex (PDC) links these pathways by catalyzing the conversion of pyruvate to acetyl-CoA, yet the epigenetic mechanisms regulating PDC expres...
Sachiko Sato, A. Hasan, Mami Obara et al.· Epigenomes· 0 citations
In summary, in-depth elucidation of the molecular mechanisms underlying macrophage metabolic reprogramming and their metabolic crosstalk with breast cancer cells will provide new insights and novel therapeutic targets for the precise immunometabolic therapy of breast cancer.
Jiao-Yu Zhang, Ru-Yu-Wang-Hsin-Ti Yang· Cancer Treatment and Researc...· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is among the most hypoxic human tumors. Because fatty acid (FA) desaturation is oxygen-dependent, hypoxia can limit monounsaturated FA (MUFA) production, increase membrane lipid saturation, and activate endoplasmic reticulum stress responses, including IRE1α-XBP1s. Here, we found...
Yan-Qing Jiang, Cassidy Pagen, Gusangyu Yin et al.· Proceedings of the National...· 0 citations
Cancer stem cells (CSCs) can adapt their metabolism, which limits the effectiveness of therapies targeting metabolic pathways. Here we show that high glucose conditions promote metformin resistance in CD133⁺ colorectal CSCs by driving a switch from glucose dependence to lipid use. Mechanistically, metformin increases...
Xiangrui Li, Li Deng, Tian-Ge Zhang et al.· Nature Communications· 0 citations
Metabolic reprogramming is a hallmark of cancer cells, and stem-like populations often upregulate aldehyde dehydrogenases (ALDHs). Functional studies have established essential roles for individual ALDH isoforms in tumor initiation, progression, and metastasis; however, the mechanisms by which these enzymes promote mal...
Zhi-Ping Feng, Thomas E. Bearrood, Sydney L. Campbell et al.· bioRxiv· 0 citations
This article systematically reviews the molecular mechanisms underlying the dysregulation of three major nutrient metabolic pathways—glucose, lipid, and amino acid metabolism—and their interconnected regulatory networks and suggests a novel approach to improving the prognosis of pancreatic cancer.
Ze-Liang Zhang, Ying Tian, Bo Zhang et al.· Cytotechnology (Dordrecht)· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.